CN106966912A - (R) preparation method of 3 amino butanols - Google Patents

(R) preparation method of 3 amino butanols Download PDF

Info

Publication number
CN106966912A
CN106966912A CN201710213571.7A CN201710213571A CN106966912A CN 106966912 A CN106966912 A CN 106966912A CN 201710213571 A CN201710213571 A CN 201710213571A CN 106966912 A CN106966912 A CN 106966912A
Authority
CN
China
Prior art keywords
compound
preparation
amino
added
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710213571.7A
Other languages
Chinese (zh)
Other versions
CN106966912B (en
Inventor
刘劲松
王平
于淑玲
张少平
周文峰
王辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CANGZHOU SENARY CHEMICAL TECHNOLOGY Co Ltd
Original Assignee
CANGZHOU SENARY CHEMICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CANGZHOU SENARY CHEMICAL TECHNOLOGY Co Ltd filed Critical CANGZHOU SENARY CHEMICAL TECHNOLOGY Co Ltd
Priority to CN201710213571.7A priority Critical patent/CN106966912B/en
Publication of CN106966912A publication Critical patent/CN106966912A/en
Application granted granted Critical
Publication of CN106966912B publication Critical patent/CN106966912B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to pharmaceutical intermediate synthesis technical field, a kind of preparation method of the amino butanol of Du Lutewei intermediates (R) 3 is specifically disclosed, is with 3(Boc amino)Butyric acid is initiation material, and type I compound is obtained by chiral resolution;Again the compound of formula II is obtained by sodium borohydride and lewis acid reduction;Last amino deprotection obtains (R) 3 amino butanol.Raw material used in the inventive method is cheap and easy to get, and reaction condition is gentle, and security is reliable, and technology stability is good, high income, and optical purity is high, and environmental protection is suitable for industrialized production.

Description

(R) preparation method of -3- amino butanols
Technical field
The present invention relates to pharmaceutical intermediate synthesis technical field.
Background technology
Du Lutewei, also known as De Luogewei, English name:Dolutegravir, trade name:Tivicay, is by Britain's system Medicine giant's GlaxoSmithKline PLC(GSK)With Japanese Shionogi company(Shionogi)A kind of anti-AIDS of cooperative development is new Medicine.
(R) -3- amino butanols are the important intermediates for synthesizing Du Lutewei, and its structural formula is as follows:
Prior art prepare the problem of intermediate is present be mainly reflected in it is following some:Reaction scheme is longer, overall to receive Rate is low, and technological operation is harsher, needs to use toxic articles and explosive sensitive materials.
The content of the invention
The technical problem to be solved in the present invention is to provide a kind of preparation method of (R) -3- amino butanols, with reaction scheme Short, mild condition, safe and reliable, technology stability are good, energy consumption is low, high income the advantages of, obtained (R) -3- amino butanols Optical purity is high, and the inventive method environmental protection is suitable for industrialized production.
In order to solve the above technical problems, the technical solution used in the present invention is:(R) preparation method of -3- amino butanols, Comprise the following steps:
S1, with 3-(T-butoxycarbonyl-amino)Butyric acid is raw material, and its chiral resolution is obtained into type I compound;
S2, by type I compound sodium borohydride and lewis acid reduction obtain the compound of formula II;
S3, the compound of formula II is sloughed into tertbutyloxycarbonyl obtain (R) -3- amino butanols;
Reaction equation is as follows:
Further, the step S1 chiral resolutions include:
By 3-(T-butoxycarbonyl-amino)Butyric acid is dissolved in organic solvent, under agitating and heating state, preferably controls temperature 40~75 DEG C, add resolving agent thereto, insulated and stirred for a period of time, is cooled to 10~15 DEG C, suction filtration, dry carboxylate;
Gained carboxylate is added in ethanol, 70~75 DEG C are heated to, after insulation a period of time, 10~15 DEG C are cooled to, suction filtration, Dry, repeat this operation, until gained carboxylate ee values are more than 99%;
It is finally that carboxylate is soluble in water, concentrated hydrochloric acid is added, its pH value is adjusted to 1~2, is extracted with ethyl acetate, organic phase is dense It is reduced to no cut and obtains type I compound.
Wherein, the organic solvent is methanol, acetone or alcohol;The resolving agent is S- phenyl ethylamines, S- naphthalene ethylamines or L- Ephedrine, is preferably added to the resolving agent and 3-(T-butoxycarbonyl-amino)The mol ratio of butyric acid is 0.7~0.9:1.
Further, the step S2 includes:
Gained type I compound is dissolved in tetrahydrofuran, 0~20 DEG C of temperature control adds sodium borohydride, then Louis is added portionwise Acid, is finished, and temperature is risen into 25~50 DEG C, insulation reaction;
After completion of the reaction, add water and be quenched, organic phase is concentrated into no cut, be recrystallized to give the compound of formula II.
Optionally, the lewis acid is zinc chloride, lithium chloride or elemental iodine.
Further, the step S3 includes:
The compound of gained formula II is dissolved in dichloromethane, trifluoroacetic acid is slowly added dropwise into system for 0~10 DEG C of temperature control, be incubated Track to raw material conversion to finish, then sodium hydroxide is added portionwise, system pH is adjusted to 9~10, filtered, concentration, distillation is obtained (R) -3- amino butanols.
It is using the beneficial effect produced by above-mentioned technical proposal:The inventive method has that reaction scheme is short, condition temperature With, safe and reliable, technology stability is good, energy consumption is low, high income the advantages of, obtained (R) -3- amino butanol optical purities It is high.The inventive method environmental protection, is suitable for industrialized production, particularly suitable for the preparation of Du Lutewei intermediates.
Embodiment
The present invention provides a kind of preparation method of Du Lutewei intermediates (R) -3- amino butanols, is with 3-(Boc- amino) Butyric acid is initiation material, and type I compound is obtained by chiral resolution;
Again the compound of formula II is obtained by sodium borohydride and lewis acid reduction;
Last amino deprotection obtains (R) -3- amino butanols.
Illustrate below and the inventive method is described in further detail.
Embodiment 1
By 20.3 g 3-(Boc- amino)Butyric acid is dissolved in 40.6 mL methanol, is heated with stirring to 40~50 DEG C, at such a temperature 10.2 mL methanol solutions of 9.1 g S- phenyl ethylamines are slowly added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10 ~15 DEG C, suction filtration, dry the g of carboxylate 14;Then 14 g carboxylates are added in 28 mL ethanol, are heated to 70~75 DEG C, 15~20 min are incubated, 10~15 DEG C are slowly dropped to, suction filtration, dry the g of carboxylate 13 repeats this operation 2 times, obtains carboxylic acid Salt 12.2 g, ee value 99.7%;Finally 12.2 g carboxylates are added in 36 mL water, pH is adjusted to 1~2, addition with concentrated hydrochloric acid 30 mL ethyl acetate are extracted twice, and are merged organic phase and are concentrated into no cut, obtain the g of type I compound 7.6.
Embodiment 2
By 30 g 3-(Boc- amino)Butyric acid is dissolved in 60 mL ethanol, is heated with stirring to 70~75 DEG C, at such a temperature slowly 15 mL ethanol solutions of 14 g S- phenyl ethylamines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, Suction filtration, dry the g of carboxylate 21.6;Then 21.6 g carboxylates are added in 43.2 mL ethanol, is heated to 70~75 DEG C, guarantor 15~20 min of temperature, are slowly dropped to 10~15 DEG C, suction filtration, dry the g of carboxylate 20, repeat this operation 2 times, obtain carboxylate 18.8 g, ee value 99.6%;Finally 18.8 g carboxylates are added in 55 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, 50 are added ML ethyl acetate is extracted twice, and is merged organic phase and is concentrated into no cut, obtains the g of type I compound 11.7.
Embodiment 3
By 50 g 3-(Boc- amino)Butyric acid is dissolved in 150 mL acetone, is heated with stirring to 40~50 DEG C, at such a temperature slowly 50 mL acetone solns of 20.9 g S- phenyl ethylamines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, suction filtration, dry the g of carboxylate 36;Then 36 g carboxylates are added in 72 mL ethanol, is heated to 70~75 DEG C, insulation 15~20 min, are slowly dropped to 10~15 DEG C, suction filtration, dry the g of carboxylate 33.8, repeat this operation 2 times, obtain carboxylate 32 g, ee value 99.7%;Finally 32 g carboxylates are added in 96 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, 80 mL second are added Acetoacetic ester is extracted twice, and is merged organic phase and is concentrated into no cut, obtains the g of type I compound 19.6.
Embodiment 4
By 50 g 3-(Boc- amino)Butyric acid is dissolved in 150 mL acetone, is heated with stirring to 40~50 DEG C, at such a temperature slowly 50 mL acetone solns of 23.9 g S- phenyl ethylamines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, suction filtration, dry the g of carboxylate 37.2;Then 37.2 g carboxylates are added in 75 mL ethanol, are heated to 70~75 DEG C, 15~20 min are incubated, 10~15 DEG C are slowly dropped to, suction filtration, dry the g of carboxylate 34.7 repeats this operation 2 times, obtains carboxylic Hydrochlorate 33.3 g, ee value 99.8%;Finally 33.3 g carboxylates are added in 100 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, plus Enter 85 mL ethyl acetate to be extracted twice, merge organic phase and be concentrated into no cut, obtain the g of type I compound 20.5.
Embodiment 5
By 50 g 3-(Boc- amino)Butyric acid is dissolved in 150 mL acetone, is heated with stirring to 40~50 DEG C, at such a temperature slowly 50 mL acetone solns of 26.9 g S- phenyl ethylamines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, suction filtration, dry the g of carboxylate 38;Then 38 g carboxylates are added in 75 mL ethanol, is heated to 70~75 DEG C, insulation 15~20 min, are slowly dropped to 10~15 DEG C, suction filtration, dry the g of carboxylate 35.2, repeat this operation 2 times, obtain carboxylate 33.8 g, ee value 99.5%;Finally 33.8 g carboxylates are added in 100 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, 85 are added ML ethyl acetate is extracted twice, and is merged organic phase and is concentrated into no cut, obtains the g of type I compound 20.8.
Embodiment 6
By 71 g 3-(Boc- amino)Butyric acid is dissolved in 142 mL methanol, is heated with stirring to 40~50 DEG C, at such a temperature slowly 35.5 mL methanol solutions of 47.8 g S- naphthalene ethylamines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, suction filtration, dry the g of carboxylate 59;Then 59 g carboxylates are added in 148 mL ethanol, is heated to 70~75 DEG C, insulation 15~20 min, are slowly dropped to 10~15 DEG C, suction filtration, dry the g of carboxylate 56.6, repeat this operation 2 times, obtain carboxylate 52 g, ee value 99.8%;Finally 52 g carboxylates are added in 156 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, 130 mL are added Ethyl acetate is extracted twice, and is merged organic phase and is concentrated into no cut, obtains the g of type I compound 27.9.
Embodiment 7
By 90 g 3-(Boc- amino)Butyric acid is dissolved in 225 mL ethanol, is heated with stirring to 70~75 DEG C, at such a temperature slowly 60 mL ethanol solutions of 58.5 g L- ephedrines are added dropwise, drop finishes, and the min of insulated and stirred 20~30 slowly cools to 10~15 DEG C, suction filtration, dry the g of carboxylate 78.5.Then 78.5 g carboxylates are added in 200 mL ethanol, are heated to 70~75 DEG C, 15~20 min are incubated, 10~15 DEG C are slowly dropped to, suction filtration, dry the g of carboxylate 75.3 repeats this operation 2 times, obtains carboxylic Hydrochlorate 69.2 g, ee value 99.7%;Finally 69.2 g carboxylates are added in 195 mL water, pH is adjusted to 1~2 with concentrated hydrochloric acid, plus Enter 150 mL ethyl acetate to be extracted twice, merge organic phase and be concentrated into no cut, obtain the g of type I compound 37.1.
Embodiment 8
115 g type I compounds are dissolved in 460 mL tetrahydrofurans, ice bath is cooled to 0~10 DEG C, then 23.7 g boron are added portionwise Sodium hydride, 0~10 DEG C of temperature control, then 230 mL tetrahydrofuran solutions of 165.4 g iodines are slowly added dropwise into system, drop finishes, It is gradually heating to 25~30 DEG C, liquid phase tracks to raw material conversion and finished, 60 mL water quenchings is added dropwise and go out reaction, is concentrated under reduced pressure into nothing and evaporates Point, 500 mL methanol are added, are warming up to after 55~60 DEG C of dissolved clarifications, 0.5 h is incubated, 1050 mL water is added dropwise at such a temperature, are dripped Finish, the h of insulated and stirred 1, then be slowly dropped to 15~20 DEG C, suction filtration dries to obtain the g of II compound of formula 97.4, yield 91%.
Embodiment 9
85 g type I compounds are dissolved in 600 mL tetrahydrofurans, ice bath is cooled to 0~10 DEG C, then 20.2 g boron are added portionwise Sodium hydride, 0~10 DEG C of temperature control, then 113.9 g zinc chloride are added portionwise into system, drip and finish, be gradually heating to 25~30 DEG C, liquid Mutually track to raw material conversion to finish, 45 mL saturated ammonium chlorides are added dropwise reaction is quenched, be concentrated under reduced pressure into no cut, add 350 mL1 Mol/L aqueous hydrochloric acid solutions and the extraction of 510 mL ethyl acetate, aqueous phase are extracted with 170 mL ethyl acetate again, merge organic phase, dense Contracting, adds 350 mL methanol, is warming up to after 55~60 DEG C of dissolved clarifications, is incubated 0.5 h, and 880 mL water are added dropwise at such a temperature, and drop finishes, The h of insulated and stirred 1, then it is slowly dropped to 15~20 DEG C, suction filtration dries to obtain the g of II compound of formula 70.2, yield 88.7%.
Embodiment 10
100 g type I compounds are dissolved in 700 mL tetrahydrofurans, ice bath is cooled to 0~10 DEG C, then 24.6 g boron are added portionwise Sodium hydride, 0~10 DEG C of temperature control, then 46 g lithium chlorides are added portionwise into system, drip and finish, be gradually heating to 25~30 DEG C, liquid phase Track to raw material conversion to finish, 55 mL saturated ammonium chlorides are added dropwise reaction is quenched, be concentrated under reduced pressure into no cut, add 400 mL1 Mol/L aqueous hydrochloric acid solutions and the extraction of 600 mL ethyl acetate, aqueous phase are extracted with 200 mL ethyl acetate again, merge organic phase, dense Contracting, adds 350 mL methanol, is warming up to after 55~60 DEG C of dissolved clarifications, is incubated 0.5 h, and 950 mL water are added dropwise at such a temperature, and drop finishes, The h of insulated and stirred 1, then it is slowly dropped to 15~20 DEG C, suction filtration dries to obtain the g of II compound of formula 83.2, yield 89.4%.
Embodiment 11
By the compound of 65 g formulas II, it is dissolved in 510 mL dichloromethane, is cooled to 0~10 DEG C, 47 g are slowly added dropwise into system Trifluoroacetic acid, insulation tracks to raw material conversion and finished, then sodium hydrate solid is added portionwise, and system pH is adjusted into 9~10, mistake Filter, concentration, distillation obtains 29.3 g (R) -3- amino butanols, yield 95.8,1H NMR (300MHz, DMSO, ppm): δ 4.48 (3H, s), 3.47 (2H, s), 2.96 (1H, s), 1.47-1.41 (2H, q), 1.02-0.99 (3H, d); LCMS (ESI), m/z, 90 [M+H] +.
The present invention is described in detail above, embodiments of the present invention carried out using specific case in the present invention Illustrate, the explanation of above example is only intended to help and understands the present invention, it is noted that for the technology people of the art For member, under the premise without departing from the principles of the invention, some improvement can be also carried out to the present invention, these improvement also fall into this hair In bright scope of the claims.

Claims (9)

  1. The preparation method of (1. R) -3- amino butanols, it is characterised in that comprise the following steps:
    S1, with 3-(T-butoxycarbonyl-amino)Butyric acid is raw material, and its chiral resolution is obtained into type I compound;
    S2, by type I compound sodium borohydride and lewis acid reduction obtain the compound of formula II;
    S3, the compound of formula II is sloughed into tertbutyloxycarbonyl obtain (R) -3- amino butanols;
    Reaction equation is as follows:
  2. 2. preparation method according to claim 1, it is characterised in that the step S1 chiral resolutions include:
    By 3-(T-butoxycarbonyl-amino)Butyric acid is dissolved in organic solvent, and under agitating and heating state, resolving agent is added thereto, Insulated and stirred for a period of time, is cooled to 10~15 DEG C, suction filtration, dry carboxylate;
    Gained carboxylate is added in ethanol, 70~75 DEG C are heated to, after insulation a period of time, 10~15 DEG C are cooled to, suction filtration, Dry, repeat this operation, until gained carboxylate ee values are more than 99%;
    It is finally that carboxylate is soluble in water, concentrated hydrochloric acid is added, its pH value is adjusted to 1~2, is extracted with ethyl acetate, organic phase is dense It is reduced to no cut and obtains type I compound.
  3. 3. preparation method according to claim 2, it is characterised in that the organic solvent is methanol, acetone or alcohol.
  4. 4. preparation method according to claim 2, it is characterised in that the resolving agent be S- phenyl ethylamines, S- naphthalene ethylamines or L- ephedrines.
  5. 5. preparation method according to claim 4, it is characterised in that add the resolving agent and 3-(Tertbutyloxycarbonyl-ammonia Base)The mol ratio of butyric acid is 0.7~0.9:1.
  6. 6. preparation method according to claim 1, it is characterised in that in the step S1, by 3-(Tertbutyloxycarbonyl-ammonia Base)Butyric acid is dissolved in organic solvent, is heated with stirring to 40~75 DEG C, and resolving agent is added thereto, and insulated and stirred is for a period of time.
  7. 7. preparation method according to claim 1, it is characterised in that the step S2 includes:
    Gained type I compound is dissolved in tetrahydrofuran, 0~20 DEG C of temperature control, adds sodium borohydride, then Louis is added portionwise Acid, is finished, and temperature is risen into 25~50 DEG C, insulation reaction;
    After completion of the reaction, add water and be quenched, organic phase is concentrated into no cut, be recrystallized to give the compound of formula II.
  8. 8. preparation method according to claim 7, it is characterised in that the lewis acid is zinc chloride, lithium chloride or iodine Simple substance.
  9. 9. preparation method according to claim 1, it is characterised in that the step S3 includes:
    The compound of gained formula II is dissolved in dichloromethane, trifluoroacetic acid is slowly added dropwise into system for 0~10 DEG C of temperature control, be incubated Track to raw material conversion to finish, then sodium hydroxide is added portionwise, system pH is adjusted to 9~10, filtered, concentration, distillation is obtained (R) -3- amino butanols.
CN201710213571.7A 2017-04-01 2017-04-01 (R) preparation method of -3- amino butanol Active CN106966912B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710213571.7A CN106966912B (en) 2017-04-01 2017-04-01 (R) preparation method of -3- amino butanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710213571.7A CN106966912B (en) 2017-04-01 2017-04-01 (R) preparation method of -3- amino butanol

Publications (2)

Publication Number Publication Date
CN106966912A true CN106966912A (en) 2017-07-21
CN106966912B CN106966912B (en) 2019-07-02

Family

ID=59336880

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710213571.7A Active CN106966912B (en) 2017-04-01 2017-04-01 (R) preparation method of -3- amino butanol

Country Status (1)

Country Link
CN (1) CN106966912B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113336655A (en) * 2020-12-30 2021-09-03 江西迪赛诺制药有限公司 Preparation method of (R) -3-aminobutanol

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417954A (en) * 2007-10-23 2009-04-29 上海雅本化学有限公司 Method for preparing optically pure 3-amino butyl alcohol
WO2014009447A1 (en) * 2012-07-11 2014-01-16 F. Hoffmann-La Roche Ag ARYL SULTAM DERIVATIVES AS RORc MODULATORS
WO2014128545A2 (en) * 2013-02-19 2014-08-28 Aurobindo Pharma Limited An improved process for the preparation of dolutegravir
CN104178533A (en) * 2014-07-31 2014-12-03 洛阳华荣生物技术有限公司 Method for producing R-3-aminobutanol
CN104370755A (en) * 2014-08-18 2015-02-25 江西隆莱生物制药有限公司 Preparation method for optical activity active 3-amino butanol and optical activity 3-amino butyric acid
CN105916852A (en) * 2014-01-10 2016-08-31 豪夫迈·罗氏有限公司 Aryl sultam derivatives as RORc modulators

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417954A (en) * 2007-10-23 2009-04-29 上海雅本化学有限公司 Method for preparing optically pure 3-amino butyl alcohol
WO2014009447A1 (en) * 2012-07-11 2014-01-16 F. Hoffmann-La Roche Ag ARYL SULTAM DERIVATIVES AS RORc MODULATORS
WO2014128545A2 (en) * 2013-02-19 2014-08-28 Aurobindo Pharma Limited An improved process for the preparation of dolutegravir
CN105916852A (en) * 2014-01-10 2016-08-31 豪夫迈·罗氏有限公司 Aryl sultam derivatives as RORc modulators
CN104178533A (en) * 2014-07-31 2014-12-03 洛阳华荣生物技术有限公司 Method for producing R-3-aminobutanol
CN104370755A (en) * 2014-08-18 2015-02-25 江西隆莱生物制药有限公司 Preparation method for optical activity active 3-amino butanol and optical activity 3-amino butyric acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张春华 等: "一种改进的制备手性氨基醇的方法", 《有机化学》 *
胡建强 等: "氨基酸手性拆分研究进展", 《食品与药品》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113336655A (en) * 2020-12-30 2021-09-03 江西迪赛诺制药有限公司 Preparation method of (R) -3-aminobutanol

Also Published As

Publication number Publication date
CN106966912B (en) 2019-07-02

Similar Documents

Publication Publication Date Title
CN114805314A (en) Synthesis method of Ensaitevir
WO2023284058A1 (en) Method for preparing chiral synthetic nicotine
CN114437031A (en) Synthetic method of 6-methyl nicotine
CN109503568B (en) Preparation method of dasatinib
CN106966912A (en) (R) preparation method of 3 amino butanols
CN102442972A (en) Industrial preparation method for pramipexole and its dihydrochloride monohydrate
CN108558715B (en) Method for preparing enantiopure tert-butyl sulfenamide
CN107673978B (en) Intermediate of 2, 2-difluorocycloalkyl methylamine and preparation method thereof
CN107216335B (en) A kind of tert-butyl 1- (methylol) -3- oxa- -9- azaspiro [5.5] hendecane -9- formic acid base ester preparation method
CN108546266B (en) Synthesis method of 1,4,6, 7-tetrahydropyrane [4,3-C ] pyrazole-3-carboxylic acid
CN106045995A (en) Synthesizing method of 5-bromine-1H-pyrrolo[2,3-b]pyridine
CN112645801A (en) Method for preparing o-fluorophenol by one-pot method
CN110734398B (en) New preparation method of 2-chloronicotinic acid
CN113501771A (en) Preparation method of N- (2-aminoethyl) glycine derivative
CN112745254A (en) Preparation method and application of 4-hydroxy-2-oxo-1-pyrrolidine acetic acid
CN108129430A (en) A kind of synthetic method of Li Tasite intermediates
CN104557885B (en) A kind of preparation method of Rosuvastatin impurity A
CN104892608B (en) A kind of synthetic method of minitrogen alcohol
CN108658931A (en) A kind of preparation method of Raltitrexed key intermediate
CN109574860A (en) A method of preparing Vilantro
CN111018692B (en) Method for preparing 1,2,3, 4-tetrahydro-1-naphthoic acid by super-strong alkali method
CN102993167B (en) Preparation method of selenium caprylate
CN110862311B (en) Synthesis method of 1-hydroxycyclopropanecarboxylic acid and carboxylate
JPH09176139A (en) Improved production of 5-hydroxymethylthiazole
CN112300059B (en) Preparation method of PF-06651600 intermediate

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: (R) Preparation of 3-aminobutanol

Effective date of registration: 20210420

Granted publication date: 20190702

Pledgee: Bank of Cangzhou Limited by Share Ltd. branch

Pledgor: CANGZHOU SENARY CHEMICAL SCIENCE-TEC Co.,Ltd.

Registration number: Y2021990000345

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230418

Granted publication date: 20190702

Pledgee: Bank of Cangzhou Limited by Share Ltd. branch

Pledgor: CANGZHOU SENARY CHEMICAL SCIENCE-TEC CO.,LTD.

Registration number: Y2021990000345